Skip to main content
. Author manuscript; available in PMC: 2020 Oct 29.
Published in final edited form as: Clin Cancer Res. 2017 Mar 22;23(15):4163–4169. doi: 10.1158/1078-0432.CCR-16-2658

Table 2. Adverse events.

All adverse events attributed as at least possibly-related to ONC201 were Grade 1 (n=28).

ONC201 (mg) 125 250 375 500 625
No of Patients 1 1 1 1 24
Pyrexia 1 (3.6%) 0 0 0 0
Fatigue 1 (3.6%) 0 0 0 0
Elevated amylase 0 0 0 0 2 (7.2%)
Emesis 0 0 0 0 1 (3.6%)
Nausea 0 0 0 0 1 (3.6%)